Revised April 2012
Long Day's Journey into Night
By Eugene O'Neill
42nd National Council Mental Health and Addictions Conference Location Panel Members:
Linda Rosenberg, MSW
Linda Rosenberg has 30+ years of mental health policy and practice experience, focusing on the design, financing, and management of behavioral health services.
Since 2004, Ms. Rosenberg has been President and CEO of the National Council for Community Behavioral Healthcare, a not-for-profit advocacy and educational association of almost 1,800 organizations that provide treatment and support services to 6 million adults and children with mental illnesses and addictions. Under Ms. Rosenberg’s leadership, the National Council has more than doubled its membership; helped to secure the passage of the federal mental health and addiction parity law; expanded financing for integrated behavioral health/primary care services; was instrumental in bringing behavioral health to the table in federal healthcare reform; and played a key role in introducing the Mental Health First Aid public education program in the United States.
Prior to joining the National Council, Rosenberg served as the Senior Deputy Commissioner for the New York State Office of Mental Health where she strengthened the voice of consumers and families in the policy making process; promoted the adoption of evidence-based practices including tripling New York’s assertive community treatment capacity; expanded children’s services; developed housing options for people with mental illnesses and addictions; and implemented a network of jail diversion programs including New York’s first mental health court.
A certified social worker, family therapist, and psychiatric rehabilitation practitioner, Ms. Rosenberg has held faculty appointments at a number of schools of social work and serves on many agency and editorial boards.
Carl Clark, M.D.
Dr. Carl Clark is the current CEO and former Medical Director of The Mental Health Center of Denver, a private, not-for-profit community mental health care organization providing comprehensive, recovery-focused services to more than 6,500 residents in the Denver metro area.
In 1993, Dr. Clark was chosen as NAMI’s Exemplary Psychiatrist of the Year and in 2000, he was elected Professional Man of the Year by the Colorado Business Council. Dr. Clark is also Assistant Clinical Professor at the Department of Psychiatry at the University of Colorado School of Medicine.
Northwestern University Feinberg School of Medicine Location Panel Members:
Daniel H. Angres, M.D.
Dr. Angres is the medical director of Resurrection Addiction Services and an Adjunct Associate Professor of Psychiatry at Feinberg School of Medicine, Northwestern University. He has been involved in addiction psychiatry for thirty years with specialization in the assessment and treatment of addicted healthcare and other professionals. He teaches and conducts research on topics such as the role of personality assessment in treatment planning and outcomes.
Michael Fleming, M.D., MPH
Dr. Michael Fleming is a physician and scientist who has devoted much of his career to caring for people and families affected by alcoholism and drug addiction. He is a Professor of Psychiatry and Family and Community Medicine at the Northwestern University Feinberg School of Medicine. Dr. Fleming is also a member of the Institute of Medicine of the National Academies.
Daniel McGehee, PhD
Dr. McGehee is an Associate Professor of Neuroscience at the University of Chicago in the Department of Anesthesia and Critical Care. He also serves on the Committee on Neurobiology and is a member of the Institute for Integrative Physiology. Dr. McGehee investigates the cellular mechanisms underlying the reinforcing or addictive properties of nicotine. His lab was the first to show that memory mechanisms involved in conscious memories are also induced by nicotine in brain reward areas. His research is continuing to explore the memory trace that links nicotine exposure to addiction.
His research is supported by a range of funding agencies such as the National Institute on Drug Abuse, National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke, NIH, and results of his work are published in leading peer-review journals as well as in publications targeting clinical practice.